The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat

Currently, treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) is focused on three signaling pathways: the NO pathway, the endothelin pathway, and the prostacyclin pathway. Riociguat is the only representative of stimulators of the soluble gua...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	S. E. Gratsianskaya, Z. S. Valieva, T. V. Martynyuk
Materyal Türü:	Artigo
Dil:	Russo
Baskı/Yayın Bilgisi:	"Consilium Medicum" Publishing house 2020-10-01
Seri Bilgileri:	Терапевтический архив
Konular:	pulmonary arterial hypertension chronic thromboembolic pulmonary hypertension stimulators of the soluble guanylate cyclase riociguat
Online Erişim:	https://ter-arkhiv.ru/0040-3660/article/viewFile/46859/32012
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!